lvl up bpc 157 BPC157: Re-Generate – I Took BPC 157 Peptide

Retatrutide (LY3437943) is a triple GIP/GLP-1/glucagon receptor agonist developed by Eli Lilly

Injections are subcutaneous (SQ) using an insulin syringe, administered at home after the first clinic injection

A 26-week diabetes study measured human activity at 1 mg, but its endpoint was blood sugar rather than long-term weight. A short outpatient cohort measured about 4.7% weight loss over four weeks at 2.5 mg. Below 1 mg, estimates rely on pharmacokinetics and mechanism

We see patients in Chiang Mai and Phuket, and regularly support individuals in Bangkok, Pattaya, Hua Hin, Krabi, and Koh Samui

Shifting the interval to 5 or 9 days creates blood level fluctuations that can affect both efficacy and side effects